CRISPR-enabled ultrasensitive surface-enhanced Raman scattering sensing platform for background-free detection of phosphorylated tau in Alzheimer's disease
Biosensors and Bioelectronics · 2027-02 · 318 · 119400
DOI: 10.1016/j.bios.2026.119400 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2027-02. Verfasst von Xiaoyi Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Xiamen Key Laboratory of Genetic Testing, The First Affiliated Hospital of Xiamen University, School of Medicine, …. Die Arbeit nennt 36 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Accurate and ultrasensitive detection of phosphorylated tau at threonine 231 (P-tau231), a pathologically validated early biomarker of Alzheimer's disease (AD), is essential for preclinical diagnosis and longitudinal monitoring. However, blood-based detection remains challenging because of the femtomolar physiological abundance, substantial interference from the serum matrix, and the reliance of conventional clustered regularly interspaced short palindromic repeats (CRISPR) assays on nucleic acid amplification. Herein, we present an amplification-free CRISPR/Cas12a-assisted surface-enhanced Raman scattering (SERS) aptasensor for the background-free quantification of P-tau231. This platform integrates aptamer-mediated target recognition, programmable Cas12a trans-cleavage-based signal transduction, and hierarchical plasmonic enhancement. Au-4-Mercaptobenzonitrile@Au (Au-4-MBN@Au) core-shell nanoprobes coupled with Ag nanocube arrays provide uniform plasmonic enhancement, while the characteristic C ≡ N peak of the 4-MBN reporter at 2230 cm-1 lies within the biological Raman-silent window (1800-2800 cm-1), thereby minimizing inference from endogenous scattering. This biosensor exhibits a linear detection range of 50 fg/mL to 5 ng/mL and an ultralow limit of detection of 2.53 fg/mL. Overall, this work established an effective amplification-free CRISPR/Cas12a-SERS platform for the highly sensitive detection of serum P-tau231 and offers a promising analytical approach for the blood-based early diagnosis of AD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Xiamen Key Laboratory of Genetic Testing, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen, University, Xiamen, 361005, PR China; Fujian University of Tra…
- Department of Laboratory Medicine, Xiamen Key Laboratory of Genetic Testing, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen, University, Xiamen, 361005, PR China.
- Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, PR China.
- Department of Laboratory Medicine, Xiamen Key Laboratory of Genetic Testing, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen, University, Xiamen, 361005, PR China. Electronic address: jiam…
- Ministry of Education Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection for Food Safety, Department of Chemistry, Fuzhou University, Fuzhou, 350…
- Department of Laboratory Medicine, Xiamen Key Laboratory of Genetic Testing, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen, University, Xiamen, 361005, PR China. Electronic address: xmhg…
Zitieren
APA
Chen, X., Yang, Y., Liao, Y., Chen, L., Cheng, L., Su, C., Shi, X., Chen, J., Lin, Z., & Hong, G. (2027). CRISPR-enabled ultrasensitive surface-enhanced Raman scattering sensing platform for background-free detection of phosphorylated tau in Alzheimer's disease. Biosensors and Bioelectronics, 318, 119400. https://doi.org/10.1016/j.bios.2026.119400
Vancouver
Chen X, Yang Y, Liao Y, Chen L, Cheng L, Su C, et al. CRISPR-enabled ultrasensitive surface-enhanced Raman scattering sensing platform for background-free detection of phosphorylated tau in Alzheimer's disease. Biosensors and Bioelectronics. 2027;318:119400. doi:10.1016/j.bios.2026.119400
BibTeX
@article{Chen2027,
author = {Chen, Xiaoyi and Yang, Yuanyuan and Liao, Yimin and Chen, Lu and Cheng, Lingjun and Su, Canping and Shi, Xuan and Chen, Jiaming and Lin, Zhenyu and Hong, Guolin},
title = {CRISPR-enabled ultrasensitive surface-enhanced Raman scattering sensing platform for background-free detection of phosphorylated tau in Alzheimer's disease},
journal = {Biosensors and Bioelectronics},
year = {2027},
volume = {318},
pages = {119400},
doi = {10.1016/j.bios.2026.119400}
}
EUVIMED